July 14,2006

Chairman Grassley Questions CMS, FDA About Substituted Inhalation Drugs

Please see the printer-friendly version of Chairman Grassley's letter CMS and FDA regarding substituted inhalation drugs.

Next Article Previous Article

Recent News

03/14/25 Crapo: Dr. Oz Undoubtedly Qualified to be CMS Administrator
03/14/25 Crapo Statement on Speaking with SSA Commissioner Nominee
03/14/25 Finance Committee Advances Deputy Treasury Secretary Nominee
03/14/25 Crapo Statement at CMS Nomination Hearing
03/14/25 Crapo Statement at Executive Session to Consider Deputy Treasury Secretary Nominee